SCHEMBL735049

SCHEMBL735049

COc1cc2[nH]cc(CCO)c2cc1F

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 2/20 0.63
HTR2B P41595 2/20 0.60
CYP2D6 P10635 3/20 0.57
MTNR1A P48039 6/20 0.56
MTNR1B P49286 5/20 0.54
NPC1 O15118 1/20 0.49
HTR2C P28335 2/20 0.48
GPR84 Q9NQS5 1/20 0.46
CYP1A2 P05177 3/20 0.45
CYP3A4 P08684 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
KDM4E B2RXH2 1/20 0.45
HPGD P15428 1/20 0.45
APEX1 P27695 1/20 0.45
HSD17B10 Q99714 1/20 0.45
NFKB1 P19838 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
LMNA P02545 1/20 0.44
CYP2C9 P11712 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8001598 0.81 HTR1A (0.54) HTR1AHTR2BCYP2D6MTNR1AMTNR1B
SCHEMBL2534666 0.81 HTR1A (0.72) HTR1AHTR2BMTNR1AMTNR1BHTR2C
SCHEMBL25028276 0.78 HTR2B (0.68) HTR1AHTR2BCYP2D6MTNR1AMTNR1B
SCHEMBL25030320 0.77 HTR1A (1.00) HTR1AHTR2BCYP2D6MTNR1AMTNR1B
SCHEMBL25028263 0.77 HTR2B (0.71) HTR1AHTR2BCYP2D6MTNR1AMTNR1B
Oxalic Acid SCHEMBL2540168 0.77 HTR2B (0.67) HTR1AHTR2BCYP2D6MTNR1AMTNR1B
SCHEMBL7850885 0.75 HTR2A (0.63) HTR1AHTR2BCYP2D6MTNR1AMTNR1B
SCHEMBL7984083 0.75 HTR2B (0.52) HTR1AHTR2BCYP2D6MTNR1AMTNR1B
SCHEMBL1772618 0.75 HTR2B (1.00) HTR1AHTR2BCYP2D6MTNR1AMTNR1B
SCHEMBL31291665 0.74 HTR2B (0.64) HTR1AHTR2BCYP2D6MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044016-B1 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM GRUENENTHAL GMBH (DE) 2012-12-05 EP disclosed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US disclosed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US disclosed
EP-2044016-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2009-04-08 EP disclosed
WO-2008009415-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1- AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES CYP3A43, HMGCR, ABCG2 HTR1A 746/4885HTR2B 759/4885CYP2D6 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.